Unilateral infusion of methionine sulfoximine (MSO) into the substantia nigra of the rat induced contralateral rotations appearing progressively after a delay of about 100 min. The rotations were maximally antagonized by picrotoxin and bicuculline intraperitoneally injected at approximately 50-80 min after the intranigral infusion of MSO. Contraversive turning behaviour was absent after intranigral infusion of MSO in unilaterally 6-hydroxydopamine-lesioned rats.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/0006-8993(84)90672-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Characterization of large transgene integrations in Chinese hamster ovary cells using a bioengineered mammalian transposase.
Biotechnol Prog
January 2025
Department of Biotechnology, BOKU University of Natural Resources and Life Sciences, Vienna, Austria.
We present the first use of a bioengineered mammalian transposase system derived from Myotis lucifugus (bMLT) for integration of expression vectors into the CHO genome, focusing on GFP and trastuzumab production. Initially, CHO-K1 cells are transfected with a GFP reporter and varying amounts of bMLT DNA or mRNA. GFP expression is monitored over 17 weeks without selective pressure.
View Article and Find Full Text PDFMethionine Sulfoximine as a Tool for Studying Temporal Lobe Epilepsy: Initiator, Developer, Attenuator.
Neurochem Res
January 2025
Department of Pathophysiology, Medical University of Lublin, 20-090, Lublin, Poland.
Methionine sulfoximine (MSO) is a compound originally discovered as a byproduct of agene-based milled flour maturation. MSO irreversibly inhibits the astrocytic enzyme glutamine synthase (GS) but also interferes with the transport of glutamine (Gln) and of glutamate (Glu), and γ-aminobutyric acid (GABA) synthesized within the Glu/Gln-GABA cycle, in this way dysregulating neurotransmission balance in favor of excitation. No wonder that intraperitoneal administration of MSO has long been known to induce behavioral and/or electrographic seizures.
View Article and Find Full Text PDFDLBCL cells with ferroptosis morphology can be detected with a deep convolutional neural network.
Biomed Pharmacother
January 2025
Medical Research Center, Oulu University Hospital, Oulu, Finland; Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland; Biomedicine and Internal Medicine Research Unit, University of Oulu, Oulu, Finland.
It has been demonstrated that diffuse large B-cell lymphoma (DLBCL) is especially sensitive to ferroptosis. Currently, confirming the presence of ferroptosis requires flow cytometry, which is a time consuming and labor-intensive task. Blistering of the cell membrane has been shown to be a ferroptosis-specific morphological change.
View Article and Find Full Text PDFReactive Oxygen Species-Sensitive Nanophotosensitizers Composed of Buthionine Sulfoximine-Conjugated Chitosan Oligosaccharide for Enhanced Photodynamic Treatment of Cancer Cells.
Int J Mol Sci
November 2024
Department of Dental Materials, College of Dentistry, Chosun University, Gwangju 61452, Republic of Korea.
The efficacy of photodynamic therapy (PDT) based on traditional photosensitizers is generally limited by the cellular redox homeostasis system due to the reactive oxygen species (ROS) scavenging effect of glutathione (GSH). In this study, buthionine sulfoximine (BSO), a GSH inhibitor, was conjugated with the amine group of chitosan oligosaccharide (COS) using a thioketal linker (COSthBSO) to liberate BSO and chlorine e6 (Ce6) under oxidative stress, and then, Ce6-COSthBSO NP (Ce6-COSthBSO NP), fabricated by a dialysis procedure, showed an accelerated release rate of BSO and Ce6 by the addition of hydrogen peroxide, indicating that nanophotosensitizers have ROS sensitivity. In the in vitro cell culture study using HCT116 colon carcinoma cells, a combination of BSO and Ce6 efficiently suppressed the intracellular GSH and increased ROS production compared to the sole treatment of Ce6.
View Article and Find Full Text PDFCreating Single-Cell Protein-Producing Mutants Using Chemical Mutagen and Amino Acid Inhibitors.
Scientifica (Cairo)
November 2024
Institute of Energy Systems and Environment, Riga Technical University, Azenes Street 12/1, LV 1048, Riga, Latvia.
Due to population growth and climate changes, there is a rising need for alternative food and protein sources to reduce protein scarcity and the environmental impact of food industries. Single-cell proteins (SCPs) have the potential to partially or fully substitute plant- and animal-derived dietary proteins. is an appealing bacterium for SCP production because of its fast growth and ability to obtain high protein and essential amino acid (AA) content in its biomass.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!